Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:2596-2604
Published online before print May 16, 2005, doi: 10.1161/CIRCULATIONAHA.104.490979
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/20/2596    most recent
CIRCULATIONAHA.104.490979v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lancel, S.
Right arrow Articles by Neviere, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lancel, S.
Right arrow Articles by Neviere, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Heart Diseases
*Sepsis
Related Collections
Right arrow Contractile function
Right arrow Other heart failure
Right arrow Apoptosis

(Circulation. 2005;111:2596-2604.)
© 2005 American Heart Association, Inc.


Heart Failure

Ventricular Myocyte Caspases Are Directly Responsible for Endotoxin-Induced Cardiac Dysfunction

Steve Lancel, PhD; Olivier Joulin, MD; Raphael Favory, MD; Jean Francois Goossens, PhD; Jérome Kluza, PhD; Claude Chopin, MD; Pierre Formstecher, MD, PhD; Philippe Marchetti, MD, PhD*; Remi Neviere, MD, PhD*

From EA 2689, CHRU, and Université de Lille 2, IFR 114 IMPRT (S.L., O.J., R.F., C.C., R.N.); INSERM U459 U524, IMPRT (J.K., P.F., P.M.); Laboratoire de Chimie analytique, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Lille 2 (J.F.G.); and Département de Physiologie, Faculté de Médecine, Université de Lille 2 (S.L., O.J., R.F., R.N.), Lille, France.

Correspondence to Dr Remi Neviere, Département de Physiologie, Faculté de médecine, 1 place de Verdun, Lille Cedex 59045, France. E-mail rneviere{at}univ-lille2.fr

Received July 8, 2004; revision received January 14, 2005; accepted January 20, 2005.

Background— Although most of the deleterious effects of sepsis-induced apoptosis have been attributed to increased lymphocyte cell death, caspase activation may directly alter cell function of different organ systems. We postulated that left ventricular (LV) cardiomyocyte caspase activation is directly involved in sepsis-induced heart contractile dysfunction.

Methods and Results— LV cardiomyocytes isolated 4 hours after rat treatment with endotoxin injection (10 mg/kg) displayed major reductions in contractile reserve and myofilament response to Ca2+. Concomitantly, endotoxin also induced increases in LV cardiomyocyte caspase-3, -8, and -9-like activities, which were associated with sarcomeric structure destruction and cleavage of components of the cardiac myofilament. Interestingly, zVAD.fmk treatment of septic rat prevented LV cardiomyocyte contractile dysfunction, reductions in myofilament response to calcium, troponin T cleavage, and sarcomere destruction. Serum (10%) of endotoxin-treated rats induced contractile dysfunction, caspase-3–like activity increase, and troponin T cleavage of naive LV cardiomyocytes. The effects of septic serum were prevented in LV cardiomyocytes isolated from zVAD.fmk- or zDEVD.cmk-treated rats or LV cardiomyocytes preincubated with zVAD.fmk or zDEVD.cmk.

Conclusions— The results show an important relationship between endotoxin-induced caspase activation and reduced contractile reserve and sarcomere disarray at the level of single LV cardiomyocytes.


Key Words: apoptosis • myocardial contraction • myocytes, cardiac • inflammation • shock




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
X. Li, Y. Li, L. Shan, E Shen, R. Chen, and T. Peng
Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia
Cardiovasc Res, July 1, 2009; 83(1): 72 - 79.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Pavoine and F. Pecker
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology
Cardiovasc Res, May 1, 2009; 82(2): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Radhakrishnan, I. M. Ayoub, and R. J. Gazmuri
Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1164 - H1174.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. d. de Tassigny, A. Berdeaux, R. Souktani, P. Henry, and B. Ghaleh
The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2
Eur J Heart Fail, January 1, 2008; 10(1): 39 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. L. Carlson, D. L. Maass, J. White, P. Sikes, and J. W. Horton
Caspase inhibition reduces cardiac myocyte dyshomeostasis and improves cardiac contractile function after major burn injury
J Appl Physiol, July 1, 2007; 103(1): 323 - 330.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Hua, T. Ha, J. Ma, Y. Li, J. Kelley, X. Gao, I. W. Browder, R. L. Kao, D. L. Williams, and C. Li
Protection against Myocardial Ischemia/Reperfusion Injury in TLR4-Deficient Mice Is Mediated through a Phosphoinositide 3-Kinase-Dependent Mechanism
J. Immunol., June 1, 2007; 178(11): 7317 - 7324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Carlson, D. L. Maass, D. J. White, J. Tan, and J. W. Horton
Antioxidant vitamin therapy alters sepsis-related apoptotic myocardial activity and inflammatory responses
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2779 - H2789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ha, F. Hua, D. Grant, Y. Xia, J. Ma, X. Gao, J. Kelley, D. L. Williams, J. Kalbfleisch, I. W. Browder, et al.
Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1910 - H1918.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Larche, S. Lancel, S. M. Hassoun, R. Favory, B. Decoster, P. Marchetti, C. Chopin, and R. Neviere
Inhibition of Mitochondrial Permeability Transition Prevents Sepsis-Induced Myocardial Dysfunction and Mortality
J. Am. Coll. Cardiol., July 18, 2006; 48(2): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. S. Supinski and L. A. Callahan
Polyethylene Glycol-Superoxide Dismutase Prevents Endotoxin-induced Cardiac Dysfunction
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1240 - 1247.
[Abstract] [Full Text] [PDF]